Skip to content

Evaluating the Benefits and Safety of Lactuca Virosa for Increasing Milk Supply in New Mothers.

A Single-arm Retrospective Observational Study to Evaluate the Efficacy and Safety of Lactuca Virosa as a Galactagogue in Recently Delivered Lactating Mothers - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/09/073913
Enrollment
400
Registered
2024-09-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O924- Hypogalactia

Interventions

None listed

Sponsors

Academic Trial
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. The study will include data of patients in medical records at JIMS Hospital from 2015 to 2019. 2. Data of patients reported with agalactorrhea or hypogalactorrhea was diagnosed based on the patientâ??s perception and clinical reports will be included based on their medical records. 3. Both categories of women will be included in the study, i.e., vaginal delivery and caesarean section. 4. Includes the data of patients who were prescribed Lactuca Virosa as part of their treatment regimen for agalactorrhea or hypogalactorrhea during treatment. 5. The study will only include data of patients with complete and verifiable medical records that contain information on treatment start and end dates, dosage, and lactation outcomes.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Percentage of lactating mothers who reported an improvement in lactation.Timepoint: 7 days

Secondary

MeasureTime frame
Incidence of adverse effects experienced by study participants throughout the study period.Timepoint: 7 days;Proportion of participants in whom a dose change or a new medication was required.Timepoint: 7 days;Time taken for perceived improvement in milk production.Timepoint: 7 days

Countries

India

Contacts

Public ContactDr Reetha Krishnan

Ariv Integrative Healthcare, Yashoda hospital

reethakrishnan74@gmail.com8333041974

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026